NICHOLAS RAMOS

Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Sports Medicine CHICAGO, IL NPI 1386080802

General Payments — all program years on this page

$62,120.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 103
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,447.61 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Arthrex, Inc. $4,530.288
LIGHTBODY MEDICAL TECHNOLOGIES INC $902.118
MIMEDX Group, Inc. $15.221

By program year

Program yearAmountRecords
2018 $37,543.5415
2019 $14,582.9734
2020 $1,268.053
2021 $1,217.472
2022 $551.546
2023 $1,508.8326
2024 $5,447.6117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092757425 Lightbody Medical Technologies Inc $136.02 10/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092757427 Lightbody Medical Technologies Inc $93.57 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092757429 Lightbody Medical Technologies Inc $112.97 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092757431 Lightbody Medical Technologies Inc $14.55 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092757433 Lightbody Medical Technologies Inc $41.98 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092757435 Lightbody Medical Technologies Inc $197.56 08/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092757437 Lightbody Medical Technologies Inc $238.65 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092757439 Lightbody Medical Technologies Inc $66.81 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140267699 MIMEDX Group, Inc. $15.22 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146493026 Arthrex, Inc. $24.00 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146493030 Arthrex, Inc. $3,750.00 02/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1146493034 Arthrex, Inc. $34.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146493038 Arthrex, Inc. $24.00 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146493041 Arthrex, Inc. $30.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146493045 Arthrex, Inc. $190.98 10/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146493049 Arthrex, Inc. $238.65 12/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146493053 Arthrex, Inc. $238.65 12/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.